Table 3.
Hazard ratios expressing the impact of patient characteristics on cumulative incidence of autoimmune disease, fibromyalgia or myalgic encephalomyelitis by type of surgery
| HR | 95% CI | P value | |
|---|---|---|---|
| Surgery type | |||
| Non‐mesh | 1 | 0.07 | |
| Mesh | 0.89 | (0.78–1.01) | |
| Operation year | |||
| 2006 | 1 | 0.53 | |
| 2007 | 0.92 | (0.83–1.03) | |
| 2008 | 1.02 | (0.92–1.13) | |
| 2009 | 0.99 | (0.88–1.10) | |
| 2010 | 0.98 | (0.87–1.09) | |
| 2011 | 0.99 | (0.88–1.11) | |
| 2012 | 0.97 | (0.86–1.10) | |
| 2013 | 0.94 | (0.83–1.07) | |
| Age group (years) | |||
| 18–39 | 1 | <0.01 | |
| 40–49 | 1.28 | (1.15–1.43) | |
| 50–59 | 1.59 | (1.43–1.78) | |
| 60–69 | 2.15 | (1.92–2.40) | |
| ≥70 | 2.45 | (2.18–2.75) | |
| Deprivation | |||
| 1 Most deprived | 1 | <0.01 | |
| 2 | 0.88 | (0.82–0.96) | |
| 3 | 0.85 | (0.79–0.92) | |
| 4 | 0.80 | (0.74–0.86) | |
| 5 Least deprived | 0.75 | (0.69–0.81) | |
| Number of comorbidities | |||
| 0 | 1 | <0.01 | |
| 1 | 1.54 | (1.45–1.63) | |
| 2 | 2.28 | (2.03–2.56) | |
| 3 | 2.59 | (2.04–3.28) | |
| Ethnic group | |||
| White | 1 | 0.41 | |
| Asian/Asian British | 1.08 | (0.92–1.26) | |
| Black/Black British | 0.82 | (0.61–1.10) | |
| Other | 1.06 | (0.87–1.29) | |